{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:44:52Z","timestamp":1777934692823,"version":"3.51.4"},"reference-count":41,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Shaanxi Pharmaceutical Association Hospital Pharmacy High-Quality Development Research Project","award":["2024-1-1-1"],"award-info":[{"award-number":["2024-1-1-1"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Surface contamination from chemotherapy drugs poses occupational risks to healthcare workers, yet data from China are limited. This study assessed such contamination in healthcare facilities in Shaanxi Province.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted in 16 institutions. Surface wipe samples were collected from Pharmacy Intravenous Admixture Services (PIVAS) and drug preparation rooms in wards (DPRWs) over three days, before and after cleaning. Concentrations of cyclophosphamide (CP) and gemcitabine (Gem) were measured using HPLC-MS\/MS. Statistical analyses evaluated contamination differences across environments and cleaning effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 659 samples were analyzed. In PIVAS, median Gem and CP levels ranged from 0.00\u20131.44\u2005ng\/cm\u00b2 and 0.0011\u20131.10\u2005ng\/cm\u00b2, respectively. In DPRWs, levels ranged from 0.01\u20133.53\u2005ng\/cm\u00b2 (Gem) and 0.47\u201336.61\u2005ng\/cm\u00b2 (CP), with CP consistently higher. Contamination concentrated on biological safety cabinet (BSC) surfaces in PIVAS and cabinet windows or preparation tables in DPRWs. Cleaning significantly reduced contamination, which correlated with drug preparation volume. While DPRWs had higher median contamination, the overall difference with PIVAS was not significant. However, DPRWs equipped with BSC had notably lower contamination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hazardous drug contamination remains a concern, especially in DPRWs without BSC. Enhanced cleaning protocols and stricter safety regulations are needed to protect healthcare workers in Chinese medical settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552251376292","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T18:34:36Z","timestamp":1757961276000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["The surface contamination of hazardous drugs in different working places of healthcare facilities in shaanxi, China"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4706-6958","authenticated-orcid":false,"given":"Changkun","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiwen","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Xi\u2019an Medical College, Xi\u2019an, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengsen","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5154-0750","authenticated-orcid":false,"given":"Weihua","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"National Institute for Occupational Safety and Health. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings https:\/\/www.cdc.gov\/niosh\/docs\/2016-161\/pdfs\/2016-161.pdf (2016 accessed 12-01 2024)."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/02841860601166958"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/NAN.0000000000000361"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2020-002440"},{"key":"e_1_3_2_7_2","first-page":"761","article-title":"Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system","volume":"58","author":"Hon CY","year":"2014","unstructured":"Hon CY, Teschke K, Demers PA, et al. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system. Ann Occup Hyg 2014; 58: 761\u2013770.","journal-title":"Ann Occup Hyg"},{"key":"e_1_3_2_8_2","first-page":"1193","article-title":"OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Occupational safety and health administration","volume":"43","author":"RE Y","year":"1986","unstructured":"RE Y, Bennett D. OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Occupational safety and health administration. Am J Hosp Pharm 1986; 43: 1193\u20131204.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_3_2_9_2","unstructured":"National Institute for Occupational Safety and Health. Preventing occupational exposures to antineoplastic and other hazardous drugs in healthcare settings https:\/\/www.cdc.gov\/niosh\/docs\/2004-165\/pdfs\/2004-165.pdf (2004 accessed 10-01 2024)."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.017384"},{"key":"e_1_3_2_11_2","first-page":"141","article-title":"Cytostatics as hazardous chemicals in healthcare workers\u2019 environment","volume":"32","author":"Pa\u0142aszewska-Tkacz A","year":"2019","unstructured":"Pa\u0142aszewska-Tkacz A, Czerczak S, Konieczko K, et al. Cytostatics as hazardous chemicals in healthcare workers\u2019 environment. Int J Occup Med Environ Health 2019; 32: 141\u2013159.","journal-title":"Int J Occup Med Environ Health"},{"key":"e_1_3_2_12_2","unstructured":"Health and Safety Excutive. The Control of Substances Hazardous to Health Regulations 2002 (as amended) https:\/\/www.hse.gov.uk\/pubns\/priced\/l5.pdf (2013 accessed 10-01 2024)."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1188\/17.CJON.254-256"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155214522840"},{"key":"e_1_3_2_15_2","first-page":"60","article-title":"Analysis of antineoplastic drug utilization in hospitals from 2010 to 2011","volume":"21","author":"Diao YY","year":"2012","unstructured":"Diao YY, Zhang WP, YX DU. Analysis of antineoplastic drug utilization in hospitals from 2010 to 2011. China Pharm 2012; 21: 60\u201361.","journal-title":"China Pharm"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-019-0368-6"},{"key":"e_1_3_2_17_2","first-page":"1817","article-title":"Prescription status of antitumor drugs at Chinese hospitals","volume":"41","author":"Zhou YY","year":"2021","unstructured":"Zhou YY, Xv DX, Qi Y, et al. Prescription status of antitumor drugs at Chinese hospitals. Chin J Hosp Pharm 2021; 41: 1817\u20131822.","journal-title":"Chin J Hosp Pharm"},{"key":"e_1_3_2_18_2","unstructured":"The General Office of the National Health Commission of China. Notice of the General Office of the National Health Commission on Issuing the Guidelines for the Construction and Management of Intravenous Medication Dispensing Centers https:\/\/www.gov.cn\/zhengce\/zhengceku\/2021-12\/21\/content_5663666.htm (2021 accessed 10-01 2024)."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.22553"},{"key":"e_1_3_2_20_2","first-page":"1228","article-title":"Current status and future trends of intelligent construction of pharmacy intravenous admixture service in China: visual analysis based upon CiteSpace","volume":"44","author":"Xv ZT","year":"2024","unstructured":"Xv ZT, Ni HF, Wang MM, et al. Current status and future trends of intelligent construction of pharmacy intravenous admixture service in China: visual analysis based upon CiteSpace. Chin J Hosp Pharm 2024; 44: 1228\u20131234.","journal-title":"Chin J Hosp Pharm"},{"key":"e_1_3_2_21_2","unstructured":"National Health Commission of the People's Republic of China. Statistical Bulletin on the Development of China's Health Sector in 2023. http:\/\/www.nhc.gov.cn\/guihuaxxs\/s3585u\/202408\/6c037610b3a54f6c8535c515844fae96\/files\/58c5d1e9876344e5b1aa5aa2b083a51a.pdf (2023. accessed 02\/19 2025)."},{"key":"e_1_3_2_22_2","first-page":"179","article-title":"Study of occupational exposure risk in workers to anticancer drugs in pharmacy intravenous admixture service of a hospital","volume":"27","author":"Yin H","year":"2020","unstructured":"Yin H. Study of occupational exposure risk in workers to anticancer drugs in pharmacy intravenous admixture service of a hospital. China Mod Med 2020; 27: 179\u2013182.","journal-title":"China Mod Med"},{"key":"e_1_3_2_23_2","first-page":"1009","article-title":"Investigation and analysis of exposure to antineoplastic drugs of medical staff in sichuan province","volume":"31","author":"Hao ML","year":"2020","unstructured":"Hao ML, Zhu YB, Q J, et al. Investigation and analysis of exposure to antineoplastic drugs of medical staff in sichuan province. Chin Pharm 2020; 31: 1009\u20131014.","journal-title":"Chin Pharm"},{"key":"e_1_3_2_24_2","article-title":"Environmental contamination with cytotoxic drugs in 15 hospitals from 11 European countries\u2014results of the MASHA project","volume":"3","author":"Korczowska E","year":"2020","unstructured":"Korczowska E, Crul M, Tuerk J, et al. Environmental contamination with cytotoxic drugs in 15 hospitals from 11 European countries\u2014results of the MASHA project. Eur J Hosp Pharm 2020; 3: e24.","journal-title":"Eur J Hosp Pharm"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1235496"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1177\/10781552231205481"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2023.11"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-023-01963-y"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/10781552211023571"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-015-8868-y"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/10781552211072877"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v70i6.1708"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/19338244.2013.763757"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-007-0181-4"},{"key":"e_1_3_2_35_2","first-page":"703","article-title":"Guidance values for surface monitoring of antineoplastic drugs in German pharmacies","volume":"53","author":"Schierl R","year":"2009","unstructured":"Schierl R, B\u00f6hlandt A, Nowak D. Guidance values for surface monitoring of antineoplastic drugs in German pharmacies. Ann Occup Hyg 2009; 53: 703\u2013711.","journal-title":"Ann Occup Hyg"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155210380485"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2019-002165"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-021-01671-5"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220915961"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.4081\/gimle.447"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/annweh\/wxx065"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp050258"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552251376292","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552251376292","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552251376292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:31:43Z","timestamp":1777689103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552251376292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":41,"alternative-id":["10.1177\/10781552251376292"],"URL":"https:\/\/doi.org\/10.1177\/10781552251376292","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"article-number":"10781552251376292"}}